A full complement of services with tailored solutions and strategies specifically for the MedTech industry. We have supported trials since 2007, with expertise in trial design and implementation for a wide range of products, including Medical Devices, In Vitro Diagnostics, Combination Device-Drug products, and SaMD.
RQM+ provides comprehensive clinical trial management services. To ensure that results meet your expectations and are delivered on time, we work collaboratively with sponsors and sites to anticipate challenges and proactively manage trials.
We also provide real-time data access to manage the enrollment and performance of your sites and surgical operators. Our clinical research associates and trial experts specialize in multiple data review and capture methods to deliver best-in-class data reconciliations.
Our clinical operations teams are mapped to your clinical trial by expertise and years of experience -- providing the best on-site results for enrollment, strategic planning and communication.
Our services include:
Our Quality Management System (QMS) ensures that our services are compliant with all applicable regulatory quality standards, guidelines and laws, while also supporting the data integrity and safety of your trial. Additionally, our quality services team prepares you for any kind of inspection/audit. Proactive inspection preparation results in fewer findings and higher-quality data.
We offer:
Our clinical safety team will drive the end-to-end safety management set up, coordination and reporting for your clinical trial. In coordination with our medical affairs team, we provide a seamless and on-time deliverable model to ensure all safety events and patient criteria are communicated, analyzed and reported.
Our safety services include:Our MedTech study start-up experts provide strategic oversight and leadership in all aspects of start-up and site activation for your clinical journey, inclusive of timelines and local and global regulatory requirements.
Finally, we prepare the sites for initiation by:Our transparent process gives you real-time data access during every clinical stage so that you can make well-informed decisions earlier in the trial. Our data management team ensures your data is reported, displayed, captured and fully compliant with global data and reporting requirements.
Our services include:Our biometrics team will recommend a customized program to design, collect, analyze, standardize and report your clinical trial data.
Our biostatistcs services include:Project management is essential in MedTech clinical trials to maintain and drive continuity and efficiency with our sponsors and internal stakeholders -- ensuring high-quality deliverables no matter the functional area of support.
Project managers are responsible for delivering all aspects of the clinical trial on time and on budget while meeting quality expectations. Whether it is your early feasibility study (EFS), 510(k), CE mark, premarket approval, post-market surveillance, decentralized trial or SaMD trial, we ensure efficient delivery of your project based on our:
RQM+ medical and scientific affairs physician experts leverage their experience with medical devices, combination products and diagnostics to provide the most suitable advisory and strategic methodology for your pre-market or commercial product and indication.
We consider all applicable treatment guidelines, processes and impacts via the regulatory landscape to ensure safety and quality standards for your clinical trial.
Our clinical trials medical affairs support includes:
At RQM+, our medical writing team is an integral partner from the very beginning of your project, collaborating closely with you to define trial specifics, align with regulatory frameworks, and design studies and outcome measures that meet your unique goals.
Our medically and scientifically trained experts craft study protocols for your medical device trial that tie together State-of-the-Art, patient characteristics, treatment strategies, and the intended use of your medical device.
We deliver high-quality interim and final reports, and we prepare manuscripts that adhere to academic standards, ensuring seamless publication of your study protocols or results.
Whether your project involves randomized controlled trials (RCTs), registries, chart reviews, or post-market clinical follow-up (PMCF) studies, our medical writing team is equipped to provide the precision and expertise you need to succeed.
Our global team is comprised of engineers and scientists who understand how medical devices work, how performance is measured, and what type of documentation and evidence is required. With former regulators and notified bodies on staff, we have unique insights into how regulatory bodies and reviewers are likely to respond.
Jaishankar “Jai” joined the RQM+ clinical team in February of 2021 after seven years at BSI where he held CE marking technical and clinical leadership roles. Jai is best at leveraging his unique blend of expertise combining cardiovascular product development- and CE marking-experience, towards supporting our clients with regulatory solutions and developing clinical strategies. His fresh-from-the-notified body perspective brings great insights and creative approaches to our clients.
“The paradigm shift in EU regulatory/clinical is real but it isn’t quite like mapping Mars either. Along with the talented, knowledgeable team at RQM+, I’m committed to helping retain legacy devices on the market and ensuring patients can benefit from innovative technologies.”
Margot Borgel, Ph.D. is the Director for IVD Intelligence and Innovation at RQM+ where she provides her expertise in IVDR implementation and notified body requirements. Prior to RQM+, Margot was a Technical Specialist at BSI, where she performed technical reviews for IVDR, IVDD and UKCA certification. She is especially passionate about certification of high-risk devices and enjoyed seeing these devices through IVDR certification while at BSI. Before her notified body work, Margot worked for Immucor, Inc. where she held roles in R&D, manufacturing technical support and manufacturing.
“The RQM+ IVD Team has the tools and expertise to provide IVD organizations a clear path to successful IVDR certification.”
Cari Kniola is a clinical research professional with a strong foundation in project management and clinical trials. Her career journey, beginning with roles as a Clinical Research Associate (CRA) and Clinical Trial Manager (CTM), has led her to RQM+, where she plays a pivotal role in supporting IVD manufacturers. With her expertise centered on the strategic and operational aspects of clinical trials, Cari offers a focused and impactful approach to IVD clinical research, ensuring that projects are managed effectively and comply with the highest standards.
"At RQM+, my focus is on navigating the intricate landscape of IVD clinical research through effective project management and clinical trial expertise. Our aim is to elevate the standard of diagnostics, ensuring they are not just compliant but also significantly enhance patient care."
GLOBAL BOTTOM CTA INSTRUCTIONS:
To display custom copy instead of global copy in this section, please go to Show Global Content for Bottom CTA? toggle in the "Contents" tab to the left, toggle it off, save, and then REFRESH the page editor, the custom text will then show up and ready to be edited.
Turning the global content back on will be the same process, go to the toggle and toggle it back on, save and refresh!
United States HQ 2790 Mosside Blvd. United States (U.S.) |
Europe HQ 3rd Floor, 1 Ashley Road Altrincham, Cheshire, |
©2024 RQM+ All Rights Reserved | Privacy Policy | Cookies Policy